Alex Waterson
-
Vanderbilt Innovation Catalyst Fund continues advancing research with new review committee
The Vanderbilt Innovation Catalyst Fund, launched in 2023, bridges the gap between academic research and real-world applications by supporting projects with commercial and societal potential. To date, the fund has completed six award cycles, distributing 39 grants to VU and VUMC awardees across diverse disciplines. Read MoreSep 4, 2025
-
Vanderbilt CTTC honors five pioneering faculty as newly inducted Master Innovators
The Center for Technology Transfer and Commercialization has honored five faculty members as 2024 Master Innovators for their groundbreaking research and transformative innovations. These pioneers, recognized for achievements spanning patents, startups and impactful technologies, exemplify Vanderbilt's dedication to translating academic excellence into societal advancements. Read MoreDec 5, 2024
-
Vanderbilt-discovered cancer killing compound is now available through Boehringer Ingelheim open science portal opnMe
Researchers in the lab of Stephen Fesik, Orrin H. Ingram II Chair in Cancer Research, have added BI-0474 as the second molecule co-discovered by Vanderbilt to the open science portal opnMe.com, an initiative being driven by biopharmaceutical company Boehringer Ingelheim. Read MoreMay 30, 2024
-
VU takes key role in cancer drug discovery consortium
Vanderbilt University has been selected as one of seven Dedicated Centers in the nation for the next phase of the Chemical Biology Consortium (CBC), a national network of scientists on the leading edge of cancer drug discovery. Read MoreJun 23, 2016